All In Biotech

Drug Trial Radar · NCT05864846

A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

A Phase 4, Interventional, Multicenter, Open-Label, Single-Arm Study to Assess Behavioral and Other Co-occurring Outcomes Following Treatment With EPID(I/Y)OLEX as Add-on Therapy in Participants (Aged 1 to 65 Years Old) With Seizures Associated With Tuberous Sclerosis Complex

Last checked: Nov 20, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

79

Actual

Start

Jun 29, 2023

Primary completion

Apr 6, 2026

Study completion Apr 6, 2026

Sponsor

Lead sponsor
Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
Sponsor type
Industry
First posted
May 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 year, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate behavioral and other co-occurring outcomes with EPID(I/Y)OLEX as an add-on therapy in participants aged 1 to 65 years with tuberous sclerosis complex (TSC) who experience seizures.

Conditions

  • Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

Interventions

  • Cannabidiol Oral Solution [Epidiolex]Drug

    100 mg/ml Cannabidiol Oral solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in the most problematic behavior Numerical Rating Score (NRS) score within the TAND-SQTime frame: Baseline, Week 13, Week 26, Week 52
  2. Change in Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders Self-report, Quantified Checklist (TAND-SQ) scoreTime frame: Baseline, Week 13, Week 26, Week 52
  3. Change in Aberrant Behavior Checklist (ABC) scoreTime frame: Baseline, Week 13, Week 26, Week 52
  4. Change in Child Behavior Checklist (CBCL) scoreTime frame: Baseline, Week 26, Week 52
  5. Change in Adult Behavior Checklist (ABCL) scoreTime frame: Baseline, Week 26, Week 52
  6. Change in Adult Self-Report (ASR) scoreTime frame: Baseline, Week 26, Week 52
  7. Change in Patient-Reported Outcomes Measurement Information System (PROMIS) domains scoreTime frame: Baseline, Week 26, Week 52
  8. Change in sleep characteristics using the Children's Sleep Habits Questionnaire (CSHQ)Time frame: Baseline, Week 26
  9. Change in sleep characteristics using the Pittsburgh Sleep Quality Index (PSQI)Time frame: Baseline, Week 26
  10. Change in executive function using Behavior Rating Inventory of Executive Function (BRIEF)Time frame: Baseline, Week 26
  11. Change in caregiver-reported assessment of Quality of Life (QOL) using Pediatric Quality of Life Survey Family Impact Module (PedsQL FIM)Time frame: Baseline, Week 26
  12. Change in caregiver-reported assessment of family functioning using Pediatric Quality of Life Survey Family Impact Module (PedsQL FIM)Time frame: Baseline, Week 26
  13. Change in assessment of QOL using Pediatric Quality of Life Inventory (PedsQL)Time frame: Baseline, Week 26
  14. Change in caregiver impression of overall severity of symptoms (behavior and seizure control) using the Caregiver Global Impression of Severity (CareGI-S)Time frame: Baseline, Week 4, Week 13, Week 26, Week 52
  15. Change in participant impression of overall severity of symptoms (behavior and seizure control) using the Patient Global Impression of Severity (PGI-S)Time frame: Baseline, Week 4, Week 13, Week 26, Week 52
  16. Change in clinician impression of overall severity of symptoms (behavior and seizure control) using the Clinician Global Impression of Severity (CGI-S)Time frame: Baseline, Week 4, Week 13, Week 26, Week 52
  17. Retention RateTime frame: Baseline, Week 13, Week 26, Week 52
  18. Number of participants considered treatment respondersTime frame: Baseline, Week 4, Week 13, Week 26, Week 52
  19. Change in number of seizure-free daysTime frame: Baseline, Week 4, Week 13, Week 26, Week 52
  20. Number of participants experiencing a worsening, no change, or improvement in seizure frequencyTime frame: Baseline, Week 4, Week 13, Week 26, Week 52
  21. Change in ideation score per the Columbia-Suicide Severity Rating Scale (C-SSRS)Time frame: Baseline, Week 4, Week 13, Week 26, Week 52
  22. Change in number of suicide attempts per the C-SSRSTime frame: Baseline, Week 4, Week 13, Week 26, Week 52
  23. Change in ideation score per the Children's C-SSRSTime frame: Baseline, Week 4, Week 13, Week 26, Week 52
  24. Change in number of suicide attempts per the Children's C-SSRSTime frame: Baseline, Week 4, Week 13, Week 26, Week 52
  25. Number of participant inpatient hospitalizations due to epilepsyTime frame: Up to Week 52
  26. Number of withdrawals due to Treatment Emergent Adverse Events (TEAEs)Time frame: Up to Week 52

Locations

19 sites in 4 countries. Site status is shown where the registry gives one.

  • Children's Hospital Colorado

    Aurora, Colorado

  • Yale University School of Medicine

    New Haven, Connecticut

  • University of Florida Health - Department of Neurology

    Gainesville, Florida

  • Nicklaus Children's Health, Miami

    Miami, Florida

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Minnesota Epilepsy Group

    Roseville, Minnesota

  • Atrium Health Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Le Bonheur Children's Hospital

    Memphis, Tennessee

  • University of Texas Health Science Center at Houston - Clinical Research Unit

    Houston, Texas

  • University of Texas Health Science Center - San Antonio

    San Antonio, Texas

  • University of Virginia, Charlottesville

    Charlottesville, Virginia

  • Alberta Children's Hospital

    Calgary, Alberta, Canada

  • BC Children's Hospital

    Vancouver, British Columbia, Canada

  • The Hospital for Sick Children

    Toronto, Ontario, Canada

  • The Children's Memorial Health Institute

    Warsaw, Poland

  • University Hospitals Bristol NHS Foundation Trust

    Bristol, United Kingdom

  • Sheffield Children's NHS Foundation Trust

    Sheffield, United Kingdom

  • Evelina London Children's Hospital Guys St Thomas' NHS Foundation Trust, the Guy's Hospital

    London, England, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.